nodes	percent_of_prediction	percent_of_DWPC	metapath
Acamprosate—GRIN2B—Alzheimer's disease	0.274	1	CbGaD
Acamprosate—GRIN1—Memantine—Alzheimer's disease	0.137	0.292	CbGbCtD
Acamprosate—GRIN2A—Memantine—Alzheimer's disease	0.125	0.266	CbGbCtD
Acamprosate—GRIN2B—Memantine—Alzheimer's disease	0.125	0.266	CbGbCtD
Acamprosate—GRIN3A—Memantine—Alzheimer's disease	0.083	0.177	CbGbCtD
Acamprosate—GRM5—telencephalic ventricle—Alzheimer's disease	0.00602	0.118	CbGeAlD
Acamprosate—GRIN1—telencephalic ventricle—Alzheimer's disease	0.0038	0.0748	CbGeAlD
Acamprosate—GRIN2B—telencephalic ventricle—Alzheimer's disease	0.00363	0.0713	CbGeAlD
Acamprosate—GRM5—forebrain—Alzheimer's disease	0.00157	0.0309	CbGeAlD
Acamprosate—GRM5—telencephalon—Alzheimer's disease	0.00145	0.0284	CbGeAlD
Acamprosate—GRIN2C—forebrain—Alzheimer's disease	0.0012	0.0236	CbGeAlD
Acamprosate—GRIN2D—forebrain—Alzheimer's disease	0.00111	0.0219	CbGeAlD
Acamprosate—GRIN2C—telencephalon—Alzheimer's disease	0.0011	0.0217	CbGeAlD
Acamprosate—GRIN3A—forebrain—Alzheimer's disease	0.00105	0.0206	CbGeAlD
Acamprosate—GRIN2D—telencephalon—Alzheimer's disease	0.00102	0.0201	CbGeAlD
Acamprosate—GRIN1—forebrain—Alzheimer's disease	0.000993	0.0195	CbGeAlD
Acamprosate—GRIN3A—telencephalon—Alzheimer's disease	0.000963	0.0189	CbGeAlD
Acamprosate—GRIN2B—forebrain—Alzheimer's disease	0.000947	0.0186	CbGeAlD
Acamprosate—GRIN1—telencephalon—Alzheimer's disease	0.000913	0.018	CbGeAlD
Acamprosate—GRIN2B—telencephalon—Alzheimer's disease	0.000871	0.0171	CbGeAlD
Acamprosate—GRM5—nervous system—Alzheimer's disease	0.000854	0.0168	CbGeAlD
Acamprosate—GRIN2A—forebrain—Alzheimer's disease	0.000828	0.0163	CbGeAlD
Acamprosate—GRM5—central nervous system—Alzheimer's disease	0.000822	0.0162	CbGeAlD
Acamprosate—GRM5—cerebellum—Alzheimer's disease	0.000804	0.0158	CbGeAlD
Acamprosate—GRIN2A—telencephalon—Alzheimer's disease	0.000762	0.015	CbGeAlD
Acamprosate—SLC36A1—telencephalon—Alzheimer's disease	0.000757	0.0149	CbGeAlD
Acamprosate—GRM5—brain—Alzheimer's disease	0.000653	0.0128	CbGeAlD
Acamprosate—GRIN2C—nervous system—Alzheimer's disease	0.000651	0.0128	CbGeAlD
Acamprosate—GRIN2C—central nervous system—Alzheimer's disease	0.000626	0.0123	CbGeAlD
Acamprosate—GRIN2C—cerebellum—Alzheimer's disease	0.000612	0.012	CbGeAlD
Acamprosate—GRIN2D—nervous system—Alzheimer's disease	0.000605	0.0119	CbGeAlD
Acamprosate—GRIN2D—central nervous system—Alzheimer's disease	0.000582	0.0115	CbGeAlD
Acamprosate—GRIN2D—cerebellum—Alzheimer's disease	0.000569	0.0112	CbGeAlD
Acamprosate—GRIN3A—nervous system—Alzheimer's disease	0.000569	0.0112	CbGeAlD
Acamprosate—GRIN3A—central nervous system—Alzheimer's disease	0.000548	0.0108	CbGeAlD
Acamprosate—GRIN1—nervous system—Alzheimer's disease	0.000539	0.0106	CbGeAlD
Acamprosate—GABRG2—forebrain—Alzheimer's disease	0.000522	0.0103	CbGeAlD
Acamprosate—GRIN1—central nervous system—Alzheimer's disease	0.000519	0.0102	CbGeAlD
Acamprosate—GRIN2B—nervous system—Alzheimer's disease	0.000514	0.0101	CbGeAlD
Acamprosate—GRIN1—cerebellum—Alzheimer's disease	0.000507	0.00998	CbGeAlD
Acamprosate—GRIN2C—brain—Alzheimer's disease	0.000497	0.00978	CbGeAlD
Acamprosate—GRIN2B—central nervous system—Alzheimer's disease	0.000495	0.00974	CbGeAlD
Acamprosate—GRIN2B—cerebellum—Alzheimer's disease	0.000484	0.00952	CbGeAlD
Acamprosate—GABRG2—telencephalon—Alzheimer's disease	0.00048	0.00943	CbGeAlD
Acamprosate—GRIN2D—brain—Alzheimer's disease	0.000462	0.00909	CbGeAlD
Acamprosate—GABRA1—forebrain—Alzheimer's disease	0.000461	0.00906	CbGeAlD
Acamprosate—GRIN2A—nervous system—Alzheimer's disease	0.00045	0.00884	CbGeAlD
Acamprosate—SLC36A1—nervous system—Alzheimer's disease	0.000447	0.00878	CbGeAlD
Acamprosate—GRIN3A—brain—Alzheimer's disease	0.000435	0.00855	CbGeAlD
Acamprosate—GRIN2A—central nervous system—Alzheimer's disease	0.000433	0.00851	CbGeAlD
Acamprosate—SLC36A1—central nervous system—Alzheimer's disease	0.00043	0.00846	CbGeAlD
Acamprosate—GABRA1—telencephalon—Alzheimer's disease	0.000424	0.00833	CbGeAlD
Acamprosate—GRIN2A—cerebellum—Alzheimer's disease	0.000423	0.00832	CbGeAlD
Acamprosate—SLC36A1—cerebellum—Alzheimer's disease	0.00042	0.00827	CbGeAlD
Acamprosate—GRIN1—brain—Alzheimer's disease	0.000412	0.0081	CbGeAlD
Acamprosate—GABRB3—forebrain—Alzheimer's disease	0.000401	0.00788	CbGeAlD
Acamprosate—GRIN2B—brain—Alzheimer's disease	0.000393	0.00773	CbGeAlD
Acamprosate—GABRB3—telencephalon—Alzheimer's disease	0.000368	0.00724	CbGeAlD
Acamprosate—GRIN2A—brain—Alzheimer's disease	0.000344	0.00676	CbGeAlD
Acamprosate—SLC36A1—brain—Alzheimer's disease	0.000341	0.00671	CbGeAlD
Acamprosate—GABRG2—nervous system—Alzheimer's disease	0.000283	0.00557	CbGeAlD
Acamprosate—GABRG2—central nervous system—Alzheimer's disease	0.000273	0.00536	CbGeAlD
Acamprosate—GABRG2—cerebellum—Alzheimer's disease	0.000267	0.00524	CbGeAlD
Acamprosate—GABRA1—nervous system—Alzheimer's disease	0.00025	0.00492	CbGeAlD
Acamprosate—GABRA1—central nervous system—Alzheimer's disease	0.000241	0.00473	CbGeAlD
Acamprosate—GABRA1—cerebellum—Alzheimer's disease	0.000235	0.00463	CbGeAlD
Acamprosate—GABRB3—nervous system—Alzheimer's disease	0.000217	0.00428	CbGeAlD
Acamprosate—GABRG2—brain—Alzheimer's disease	0.000216	0.00426	CbGeAlD
Acamprosate—GABRB3—central nervous system—Alzheimer's disease	0.000209	0.00412	CbGeAlD
Acamprosate—GABRB3—cerebellum—Alzheimer's disease	0.000205	0.00402	CbGeAlD
Acamprosate—GABRA1—brain—Alzheimer's disease	0.000191	0.00376	CbGeAlD
Acamprosate—GABRB3—brain—Alzheimer's disease	0.000166	0.00327	CbGeAlD
Acamprosate—Hypertension—Galantamine—Alzheimer's disease	0.000143	0.00122	CcSEcCtD
Acamprosate—Haematuria—Memantine—Alzheimer's disease	0.000142	0.00121	CcSEcCtD
Acamprosate—Visual impairment—Donepezil—Alzheimer's disease	0.000142	0.00121	CcSEcCtD
Acamprosate—Urinary tract infection—Rivastigmine—Alzheimer's disease	0.000142	0.00121	CcSEcCtD
Acamprosate—Arthralgia—Galantamine—Alzheimer's disease	0.000141	0.0012	CcSEcCtD
Acamprosate—Chest pain—Galantamine—Alzheimer's disease	0.000141	0.0012	CcSEcCtD
Acamprosate—Myalgia—Galantamine—Alzheimer's disease	0.000141	0.0012	CcSEcCtD
Acamprosate—Epistaxis—Memantine—Alzheimer's disease	0.000141	0.0012	CcSEcCtD
Acamprosate—Anxiety—Galantamine—Alzheimer's disease	0.00014	0.0012	CcSEcCtD
Acamprosate—Unspecified disorder of skin and subcutaneous tissue—Galantamine—Alzheimer's disease	0.00014	0.0012	CcSEcCtD
Acamprosate—Sweating—Rivastigmine—Alzheimer's disease	0.00014	0.00119	CcSEcCtD
Acamprosate—Discomfort—Galantamine—Alzheimer's disease	0.000139	0.00119	CcSEcCtD
Acamprosate—Haematuria—Rivastigmine—Alzheimer's disease	0.000139	0.00119	CcSEcCtD
Acamprosate—Dry mouth—Galantamine—Alzheimer's disease	0.000138	0.00118	CcSEcCtD
Acamprosate—Epistaxis—Rivastigmine—Alzheimer's disease	0.000138	0.00117	CcSEcCtD
Acamprosate—Tinnitus—Donepezil—Alzheimer's disease	0.000137	0.00117	CcSEcCtD
Acamprosate—Confusional state—Galantamine—Alzheimer's disease	0.000136	0.00116	CcSEcCtD
Acamprosate—Haemoglobin—Memantine—Alzheimer's disease	0.000135	0.00115	CcSEcCtD
Acamprosate—Rhinitis—Memantine—Alzheimer's disease	0.000134	0.00115	CcSEcCtD
Acamprosate—Haemorrhage—Memantine—Alzheimer's disease	0.000134	0.00114	CcSEcCtD
Acamprosate—Hepatitis—Memantine—Alzheimer's disease	0.000134	0.00114	CcSEcCtD
Acamprosate—Hypoaesthesia—Memantine—Alzheimer's disease	0.000133	0.00114	CcSEcCtD
Acamprosate—Hallucination—Memantine—Alzheimer's disease	0.000133	0.00114	CcSEcCtD
Acamprosate—Shock—Galantamine—Alzheimer's disease	0.000133	0.00114	CcSEcCtD
Acamprosate—Pharyngitis—Memantine—Alzheimer's disease	0.000133	0.00113	CcSEcCtD
Acamprosate—Thrombocytopenia—Galantamine—Alzheimer's disease	0.000132	0.00113	CcSEcCtD
Acamprosate—Chills—Donepezil—Alzheimer's disease	0.000132	0.00113	CcSEcCtD
Acamprosate—Tachycardia—Galantamine—Alzheimer's disease	0.000132	0.00113	CcSEcCtD
Acamprosate—Oedema peripheral—Memantine—Alzheimer's disease	0.000132	0.00113	CcSEcCtD
Acamprosate—Haemoglobin—Rivastigmine—Alzheimer's disease	0.000132	0.00112	CcSEcCtD
Acamprosate—Rhinitis—Rivastigmine—Alzheimer's disease	0.000131	0.00112	CcSEcCtD
Acamprosate—Skin disorder—Galantamine—Alzheimer's disease	0.000131	0.00112	CcSEcCtD
Acamprosate—Haemorrhage—Rivastigmine—Alzheimer's disease	0.000131	0.00112	CcSEcCtD
Acamprosate—Hepatitis—Rivastigmine—Alzheimer's disease	0.000131	0.00112	CcSEcCtD
Acamprosate—Hyperhidrosis—Galantamine—Alzheimer's disease	0.000131	0.00112	CcSEcCtD
Acamprosate—Hypoaesthesia—Rivastigmine—Alzheimer's disease	0.00013	0.00111	CcSEcCtD
Acamprosate—Hallucination—Rivastigmine—Alzheimer's disease	0.00013	0.00111	CcSEcCtD
Acamprosate—Alopecia—Donepezil—Alzheimer's disease	0.00013	0.00111	CcSEcCtD
Acamprosate—Pharyngitis—Rivastigmine—Alzheimer's disease	0.00013	0.00111	CcSEcCtD
Acamprosate—Mental disorder—Donepezil—Alzheimer's disease	0.000129	0.0011	CcSEcCtD
Acamprosate—Oedema peripheral—Rivastigmine—Alzheimer's disease	0.000129	0.0011	CcSEcCtD
Acamprosate—Visual impairment—Memantine—Alzheimer's disease	0.000129	0.0011	CcSEcCtD
Acamprosate—Anorexia—Galantamine—Alzheimer's disease	0.000129	0.0011	CcSEcCtD
Acamprosate—Malnutrition—Donepezil—Alzheimer's disease	0.000128	0.0011	CcSEcCtD
Acamprosate—Flatulence—Donepezil—Alzheimer's disease	0.000126	0.00108	CcSEcCtD
Acamprosate—Hypotension—Galantamine—Alzheimer's disease	0.000126	0.00108	CcSEcCtD
Acamprosate—Visual impairment—Rivastigmine—Alzheimer's disease	0.000126	0.00108	CcSEcCtD
Acamprosate—Tension—Donepezil—Alzheimer's disease	0.000126	0.00108	CcSEcCtD
Acamprosate—Dysgeusia—Donepezil—Alzheimer's disease	0.000126	0.00107	CcSEcCtD
Acamprosate—Tinnitus—Memantine—Alzheimer's disease	0.000125	0.00107	CcSEcCtD
Acamprosate—Nervousness—Donepezil—Alzheimer's disease	0.000125	0.00106	CcSEcCtD
Acamprosate—Back pain—Donepezil—Alzheimer's disease	0.000124	0.00106	CcSEcCtD
Acamprosate—Muscle spasms—Donepezil—Alzheimer's disease	0.000123	0.00105	CcSEcCtD
Acamprosate—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.000123	0.00105	CcSEcCtD
Acamprosate—Insomnia—Galantamine—Alzheimer's disease	0.000122	0.00104	CcSEcCtD
Acamprosate—Tinnitus—Rivastigmine—Alzheimer's disease	0.000122	0.00104	CcSEcCtD
Acamprosate—Paraesthesia—Galantamine—Alzheimer's disease	0.000121	0.00104	CcSEcCtD
Acamprosate—Immune system disorder—Memantine—Alzheimer's disease	0.000121	0.00103	CcSEcCtD
Acamprosate—Tremor—Donepezil—Alzheimer's disease	0.00012	0.00103	CcSEcCtD
Acamprosate—Somnolence—Galantamine—Alzheimer's disease	0.00012	0.00103	CcSEcCtD
Acamprosate—Chills—Memantine—Alzheimer's disease	0.00012	0.00103	CcSEcCtD
Acamprosate—Ill-defined disorder—Donepezil—Alzheimer's disease	0.000119	0.00102	CcSEcCtD
Acamprosate—Dyspepsia—Galantamine—Alzheimer's disease	0.000119	0.00102	CcSEcCtD
Acamprosate—Anaemia—Donepezil—Alzheimer's disease	0.000119	0.00101	CcSEcCtD
Acamprosate—Alopecia—Memantine—Alzheimer's disease	0.000118	0.00101	CcSEcCtD
Acamprosate—Agitation—Donepezil—Alzheimer's disease	0.000118	0.00101	CcSEcCtD
Acamprosate—Chills—Rivastigmine—Alzheimer's disease	0.000117	0.001	CcSEcCtD
Acamprosate—Decreased appetite—Galantamine—Alzheimer's disease	0.000117	0.001	CcSEcCtD
Acamprosate—Mental disorder—Memantine—Alzheimer's disease	0.000117	0.001	CcSEcCtD
Acamprosate—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.000117	0.000996	CcSEcCtD
Acamprosate—Malnutrition—Memantine—Alzheimer's disease	0.000117	0.000995	CcSEcCtD
Acamprosate—Malaise—Donepezil—Alzheimer's disease	0.000116	0.000988	CcSEcCtD
Acamprosate—Alopecia—Rivastigmine—Alzheimer's disease	0.000116	0.000988	CcSEcCtD
Acamprosate—Constipation—Galantamine—Alzheimer's disease	0.000116	0.000987	CcSEcCtD
Acamprosate—Vertigo—Donepezil—Alzheimer's disease	0.000115	0.000984	CcSEcCtD
Acamprosate—Syncope—Donepezil—Alzheimer's disease	0.000115	0.000983	CcSEcCtD
Acamprosate—Flatulence—Memantine—Alzheimer's disease	0.000115	0.00098	CcSEcCtD
Acamprosate—Mental disorder—Rivastigmine—Alzheimer's disease	0.000115	0.00098	CcSEcCtD
Acamprosate—Tension—Memantine—Alzheimer's disease	0.000114	0.000976	CcSEcCtD
Acamprosate—Dysgeusia—Memantine—Alzheimer's disease	0.000114	0.000974	CcSEcCtD
Acamprosate—Malnutrition—Rivastigmine—Alzheimer's disease	0.000114	0.000973	CcSEcCtD
Acamprosate—Nervousness—Memantine—Alzheimer's disease	0.000113	0.000966	CcSEcCtD
Acamprosate—Loss of consciousness—Donepezil—Alzheimer's disease	0.000113	0.000963	CcSEcCtD
Acamprosate—Back pain—Memantine—Alzheimer's disease	0.000113	0.000962	CcSEcCtD
Acamprosate—Flatulence—Rivastigmine—Alzheimer's disease	0.000112	0.000959	CcSEcCtD
Acamprosate—Cough—Donepezil—Alzheimer's disease	0.000112	0.000956	CcSEcCtD
Acamprosate—Tension—Rivastigmine—Alzheimer's disease	0.000112	0.000955	CcSEcCtD
Acamprosate—Dysgeusia—Rivastigmine—Alzheimer's disease	0.000112	0.000953	CcSEcCtD
Acamprosate—Feeling abnormal—Galantamine—Alzheimer's disease	0.000111	0.000951	CcSEcCtD
Acamprosate—Convulsion—Donepezil—Alzheimer's disease	0.000111	0.000949	CcSEcCtD
Acamprosate—Hypertension—Donepezil—Alzheimer's disease	0.000111	0.000946	CcSEcCtD
Acamprosate—Nervousness—Rivastigmine—Alzheimer's disease	0.000111	0.000945	CcSEcCtD
Acamprosate—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.000111	0.000944	CcSEcCtD
Acamprosate—Back pain—Rivastigmine—Alzheimer's disease	0.00011	0.000941	CcSEcCtD
Acamprosate—Muscle spasms—Rivastigmine—Alzheimer's disease	0.00011	0.000936	CcSEcCtD
Acamprosate—Arthralgia—Donepezil—Alzheimer's disease	0.000109	0.000933	CcSEcCtD
Acamprosate—Chest pain—Donepezil—Alzheimer's disease	0.000109	0.000933	CcSEcCtD
Acamprosate—Myalgia—Donepezil—Alzheimer's disease	0.000109	0.000933	CcSEcCtD
Acamprosate—Tremor—Memantine—Alzheimer's disease	0.000109	0.000932	CcSEcCtD
Acamprosate—Anxiety—Donepezil—Alzheimer's disease	0.000109	0.00093	CcSEcCtD
Acamprosate—Ill-defined disorder—Memantine—Alzheimer's disease	0.000108	0.000923	CcSEcCtD
Acamprosate—Discomfort—Donepezil—Alzheimer's disease	0.000108	0.000922	CcSEcCtD
Acamprosate—Anaemia—Memantine—Alzheimer's disease	0.000108	0.00092	CcSEcCtD
Acamprosate—Agitation—Memantine—Alzheimer's disease	0.000107	0.000914	CcSEcCtD
Acamprosate—Dry mouth—Donepezil—Alzheimer's disease	0.000107	0.000912	CcSEcCtD
Acamprosate—Abdominal pain—Galantamine—Alzheimer's disease	0.000107	0.000912	CcSEcCtD
Acamprosate—Body temperature increased—Galantamine—Alzheimer's disease	0.000107	0.000912	CcSEcCtD
Acamprosate—Tremor—Rivastigmine—Alzheimer's disease	0.000107	0.000912	CcSEcCtD
Acamprosate—Ill-defined disorder—Rivastigmine—Alzheimer's disease	0.000106	0.000903	CcSEcCtD
Acamprosate—Confusional state—Donepezil—Alzheimer's disease	0.000106	0.000902	CcSEcCtD
Acamprosate—Anaemia—Rivastigmine—Alzheimer's disease	0.000105	0.0009	CcSEcCtD
Acamprosate—Malaise—Memantine—Alzheimer's disease	0.000105	0.000897	CcSEcCtD
Acamprosate—Agitation—Rivastigmine—Alzheimer's disease	0.000105	0.000894	CcSEcCtD
Acamprosate—Vertigo—Memantine—Alzheimer's disease	0.000105	0.000894	CcSEcCtD
Acamprosate—Syncope—Memantine—Alzheimer's disease	0.000104	0.000892	CcSEcCtD
Acamprosate—Leukopenia—Memantine—Alzheimer's disease	0.000104	0.000891	CcSEcCtD
Acamprosate—Infection—Donepezil—Alzheimer's disease	0.000104	0.000888	CcSEcCtD
Acamprosate—Shock—Donepezil—Alzheimer's disease	0.000103	0.00088	CcSEcCtD
Acamprosate—Palpitations—Memantine—Alzheimer's disease	0.000103	0.000879	CcSEcCtD
Acamprosate—Malaise—Rivastigmine—Alzheimer's disease	0.000103	0.000878	CcSEcCtD
Acamprosate—Thrombocytopenia—Donepezil—Alzheimer's disease	0.000103	0.000876	CcSEcCtD
Acamprosate—Vertigo—Rivastigmine—Alzheimer's disease	0.000102	0.000874	CcSEcCtD
Acamprosate—Loss of consciousness—Memantine—Alzheimer's disease	0.000102	0.000874	CcSEcCtD
Acamprosate—Syncope—Rivastigmine—Alzheimer's disease	0.000102	0.000873	CcSEcCtD
Acamprosate—Cough—Memantine—Alzheimer's disease	0.000102	0.000868	CcSEcCtD
Acamprosate—Hyperhidrosis—Donepezil—Alzheimer's disease	0.000101	0.000864	CcSEcCtD
Acamprosate—Convulsion—Memantine—Alzheimer's disease	0.000101	0.000862	CcSEcCtD
Acamprosate—Palpitations—Rivastigmine—Alzheimer's disease	0.000101	0.00086	CcSEcCtD
Acamprosate—Hypertension—Memantine—Alzheimer's disease	0.000101	0.000859	CcSEcCtD
Acamprosate—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.0001	0.000855	CcSEcCtD
Acamprosate—Anorexia—Donepezil—Alzheimer's disease	9.98e-05	0.000852	CcSEcCtD
Acamprosate—Hypersensitivity—Galantamine—Alzheimer's disease	9.96e-05	0.00085	CcSEcCtD
Acamprosate—Cough—Rivastigmine—Alzheimer's disease	9.95e-05	0.000849	CcSEcCtD
Acamprosate—Chest pain—Memantine—Alzheimer's disease	9.92e-05	0.000847	CcSEcCtD
Acamprosate—Arthralgia—Memantine—Alzheimer's disease	9.92e-05	0.000847	CcSEcCtD
Acamprosate—Myalgia—Memantine—Alzheimer's disease	9.92e-05	0.000847	CcSEcCtD
Acamprosate—Anxiety—Memantine—Alzheimer's disease	9.88e-05	0.000844	CcSEcCtD
Acamprosate—Convulsion—Rivastigmine—Alzheimer's disease	9.88e-05	0.000843	CcSEcCtD
Acamprosate—Hypertension—Rivastigmine—Alzheimer's disease	9.84e-05	0.00084	CcSEcCtD
Acamprosate—Discomfort—Memantine—Alzheimer's disease	9.8e-05	0.000837	CcSEcCtD
Acamprosate—Hypotension—Donepezil—Alzheimer's disease	9.79e-05	0.000836	CcSEcCtD
Acamprosate—Chest pain—Rivastigmine—Alzheimer's disease	9.7e-05	0.000829	CcSEcCtD
Acamprosate—Myalgia—Rivastigmine—Alzheimer's disease	9.7e-05	0.000829	CcSEcCtD
Acamprosate—Arthralgia—Rivastigmine—Alzheimer's disease	9.7e-05	0.000829	CcSEcCtD
Acamprosate—Dry mouth—Memantine—Alzheimer's disease	9.7e-05	0.000828	CcSEcCtD
Acamprosate—Asthenia—Galantamine—Alzheimer's disease	9.7e-05	0.000828	CcSEcCtD
Acamprosate—Anxiety—Rivastigmine—Alzheimer's disease	9.67e-05	0.000826	CcSEcCtD
Acamprosate—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	9.64e-05	0.000823	CcSEcCtD
Acamprosate—Confusional state—Memantine—Alzheimer's disease	9.59e-05	0.000819	CcSEcCtD
Acamprosate—Discomfort—Rivastigmine—Alzheimer's disease	9.59e-05	0.000819	CcSEcCtD
Acamprosate—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	9.54e-05	0.000815	CcSEcCtD
Acamprosate—Dry mouth—Rivastigmine—Alzheimer's disease	9.49e-05	0.00081	CcSEcCtD
Acamprosate—Insomnia—Donepezil—Alzheimer's disease	9.47e-05	0.000809	CcSEcCtD
Acamprosate—Infection—Memantine—Alzheimer's disease	9.45e-05	0.000807	CcSEcCtD
Acamprosate—Paraesthesia—Donepezil—Alzheimer's disease	9.4e-05	0.000803	CcSEcCtD
Acamprosate—Confusional state—Rivastigmine—Alzheimer's disease	9.38e-05	0.000801	CcSEcCtD
Acamprosate—Shock—Memantine—Alzheimer's disease	9.36e-05	0.000799	CcSEcCtD
Acamprosate—Dyspnoea—Donepezil—Alzheimer's disease	9.34e-05	0.000797	CcSEcCtD
Acamprosate—Somnolence—Donepezil—Alzheimer's disease	9.31e-05	0.000795	CcSEcCtD
Acamprosate—Thrombocytopenia—Memantine—Alzheimer's disease	9.31e-05	0.000795	CcSEcCtD
Acamprosate—Tachycardia—Memantine—Alzheimer's disease	9.28e-05	0.000792	CcSEcCtD
Acamprosate—Diarrhoea—Galantamine—Alzheimer's disease	9.25e-05	0.00079	CcSEcCtD
Acamprosate—Infection—Rivastigmine—Alzheimer's disease	9.24e-05	0.000789	CcSEcCtD
Acamprosate—Skin disorder—Memantine—Alzheimer's disease	9.24e-05	0.000789	CcSEcCtD
Acamprosate—Dyspepsia—Donepezil—Alzheimer's disease	9.22e-05	0.000787	CcSEcCtD
Acamprosate—Hyperhidrosis—Memantine—Alzheimer's disease	9.19e-05	0.000785	CcSEcCtD
Acamprosate—Shock—Rivastigmine—Alzheimer's disease	9.15e-05	0.000781	CcSEcCtD
Acamprosate—Thrombocytopenia—Rivastigmine—Alzheimer's disease	9.11e-05	0.000778	CcSEcCtD
Acamprosate—Decreased appetite—Donepezil—Alzheimer's disease	9.1e-05	0.000777	CcSEcCtD
Acamprosate—Tachycardia—Rivastigmine—Alzheimer's disease	9.08e-05	0.000775	CcSEcCtD
Acamprosate—Anorexia—Memantine—Alzheimer's disease	9.06e-05	0.000774	CcSEcCtD
Acamprosate—Gastrointestinal disorder—Donepezil—Alzheimer's disease	9.04e-05	0.000772	CcSEcCtD
Acamprosate—Skin disorder—Rivastigmine—Alzheimer's disease	9.04e-05	0.000772	CcSEcCtD
Acamprosate—Hyperhidrosis—Rivastigmine—Alzheimer's disease	8.99e-05	0.000768	CcSEcCtD
Acamprosate—Pain—Donepezil—Alzheimer's disease	8.96e-05	0.000765	CcSEcCtD
Acamprosate—Constipation—Donepezil—Alzheimer's disease	8.96e-05	0.000765	CcSEcCtD
Acamprosate—Dizziness—Galantamine—Alzheimer's disease	8.94e-05	0.000763	CcSEcCtD
Acamprosate—Hypotension—Memantine—Alzheimer's disease	8.89e-05	0.000759	CcSEcCtD
Acamprosate—Anorexia—Rivastigmine—Alzheimer's disease	8.87e-05	0.000757	CcSEcCtD
Acamprosate—Hypotension—Rivastigmine—Alzheimer's disease	8.69e-05	0.000742	CcSEcCtD
Acamprosate—Musculoskeletal discomfort—Memantine—Alzheimer's disease	8.66e-05	0.00074	CcSEcCtD
Acamprosate—Feeling abnormal—Donepezil—Alzheimer's disease	8.63e-05	0.000737	CcSEcCtD
Acamprosate—Insomnia—Memantine—Alzheimer's disease	8.6e-05	0.000734	CcSEcCtD
Acamprosate—Vomiting—Galantamine—Alzheimer's disease	8.59e-05	0.000734	CcSEcCtD
Acamprosate—Gastrointestinal pain—Donepezil—Alzheimer's disease	8.56e-05	0.000731	CcSEcCtD
Acamprosate—Paraesthesia—Memantine—Alzheimer's disease	8.54e-05	0.000729	CcSEcCtD
Acamprosate—Rash—Galantamine—Alzheimer's disease	8.52e-05	0.000728	CcSEcCtD
Acamprosate—Dermatitis—Galantamine—Alzheimer's disease	8.51e-05	0.000727	CcSEcCtD
Acamprosate—Dyspnoea—Memantine—Alzheimer's disease	8.48e-05	0.000724	CcSEcCtD
Acamprosate—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	8.48e-05	0.000724	CcSEcCtD
Acamprosate—Headache—Galantamine—Alzheimer's disease	8.47e-05	0.000723	CcSEcCtD
Acamprosate—Somnolence—Memantine—Alzheimer's disease	8.45e-05	0.000722	CcSEcCtD
Acamprosate—Insomnia—Rivastigmine—Alzheimer's disease	8.41e-05	0.000718	CcSEcCtD
Acamprosate—Dyspepsia—Memantine—Alzheimer's disease	8.37e-05	0.000715	CcSEcCtD
Acamprosate—Paraesthesia—Rivastigmine—Alzheimer's disease	8.35e-05	0.000713	CcSEcCtD
Acamprosate—Urticaria—Donepezil—Alzheimer's disease	8.32e-05	0.00071	CcSEcCtD
Acamprosate—Dyspnoea—Rivastigmine—Alzheimer's disease	8.29e-05	0.000708	CcSEcCtD
Acamprosate—Abdominal pain—Donepezil—Alzheimer's disease	8.28e-05	0.000707	CcSEcCtD
Acamprosate—Body temperature increased—Donepezil—Alzheimer's disease	8.28e-05	0.000707	CcSEcCtD
Acamprosate—Somnolence—Rivastigmine—Alzheimer's disease	8.27e-05	0.000706	CcSEcCtD
Acamprosate—Decreased appetite—Memantine—Alzheimer's disease	8.27e-05	0.000706	CcSEcCtD
Acamprosate—Gastrointestinal disorder—Memantine—Alzheimer's disease	8.21e-05	0.000701	CcSEcCtD
Acamprosate—Dyspepsia—Rivastigmine—Alzheimer's disease	8.19e-05	0.000699	CcSEcCtD
Acamprosate—Pain—Memantine—Alzheimer's disease	8.13e-05	0.000694	CcSEcCtD
Acamprosate—Constipation—Memantine—Alzheimer's disease	8.13e-05	0.000694	CcSEcCtD
Acamprosate—Decreased appetite—Rivastigmine—Alzheimer's disease	8.09e-05	0.00069	CcSEcCtD
Acamprosate—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	8.03e-05	0.000686	CcSEcCtD
Acamprosate—Nausea—Galantamine—Alzheimer's disease	8.03e-05	0.000685	CcSEcCtD
Acamprosate—Pain—Rivastigmine—Alzheimer's disease	7.95e-05	0.000679	CcSEcCtD
Acamprosate—Constipation—Rivastigmine—Alzheimer's disease	7.95e-05	0.000679	CcSEcCtD
Acamprosate—Feeling abnormal—Memantine—Alzheimer's disease	7.84e-05	0.000669	CcSEcCtD
Acamprosate—Gastrointestinal pain—Memantine—Alzheimer's disease	7.78e-05	0.000664	CcSEcCtD
Acamprosate—Hypersensitivity—Donepezil—Alzheimer's disease	7.72e-05	0.000659	CcSEcCtD
Acamprosate—Feeling abnormal—Rivastigmine—Alzheimer's disease	7.67e-05	0.000655	CcSEcCtD
Acamprosate—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	7.61e-05	0.00065	CcSEcCtD
Acamprosate—Urticaria—Memantine—Alzheimer's disease	7.55e-05	0.000645	CcSEcCtD
Acamprosate—Abdominal pain—Memantine—Alzheimer's disease	7.52e-05	0.000642	CcSEcCtD
Acamprosate—Body temperature increased—Memantine—Alzheimer's disease	7.52e-05	0.000642	CcSEcCtD
Acamprosate—Asthenia—Donepezil—Alzheimer's disease	7.51e-05	0.000642	CcSEcCtD
Acamprosate—Pruritus—Donepezil—Alzheimer's disease	7.41e-05	0.000633	CcSEcCtD
Acamprosate—Urticaria—Rivastigmine—Alzheimer's disease	7.39e-05	0.000631	CcSEcCtD
Acamprosate—Abdominal pain—Rivastigmine—Alzheimer's disease	7.35e-05	0.000628	CcSEcCtD
Acamprosate—Body temperature increased—Rivastigmine—Alzheimer's disease	7.35e-05	0.000628	CcSEcCtD
Acamprosate—Diarrhoea—Donepezil—Alzheimer's disease	7.17e-05	0.000612	CcSEcCtD
Acamprosate—Hypersensitivity—Memantine—Alzheimer's disease	7.01e-05	0.000598	CcSEcCtD
Acamprosate—Dizziness—Donepezil—Alzheimer's disease	6.93e-05	0.000591	CcSEcCtD
Acamprosate—Hypersensitivity—Rivastigmine—Alzheimer's disease	6.85e-05	0.000585	CcSEcCtD
Acamprosate—Asthenia—Memantine—Alzheimer's disease	6.82e-05	0.000583	CcSEcCtD
Acamprosate—Pruritus—Memantine—Alzheimer's disease	6.73e-05	0.000574	CcSEcCtD
Acamprosate—Asthenia—Rivastigmine—Alzheimer's disease	6.67e-05	0.00057	CcSEcCtD
Acamprosate—Vomiting—Donepezil—Alzheimer's disease	6.66e-05	0.000569	CcSEcCtD
Acamprosate—Rash—Donepezil—Alzheimer's disease	6.6e-05	0.000564	CcSEcCtD
Acamprosate—Dermatitis—Donepezil—Alzheimer's disease	6.6e-05	0.000563	CcSEcCtD
Acamprosate—Pruritus—Rivastigmine—Alzheimer's disease	6.58e-05	0.000562	CcSEcCtD
Acamprosate—Headache—Donepezil—Alzheimer's disease	6.56e-05	0.00056	CcSEcCtD
Acamprosate—Diarrhoea—Memantine—Alzheimer's disease	6.51e-05	0.000556	CcSEcCtD
Acamprosate—Diarrhoea—Rivastigmine—Alzheimer's disease	6.36e-05	0.000543	CcSEcCtD
Acamprosate—Dizziness—Memantine—Alzheimer's disease	6.29e-05	0.000537	CcSEcCtD
Acamprosate—Nausea—Donepezil—Alzheimer's disease	6.22e-05	0.000531	CcSEcCtD
Acamprosate—Dizziness—Rivastigmine—Alzheimer's disease	6.15e-05	0.000525	CcSEcCtD
Acamprosate—Vomiting—Memantine—Alzheimer's disease	6.05e-05	0.000516	CcSEcCtD
Acamprosate—Rash—Memantine—Alzheimer's disease	6e-05	0.000512	CcSEcCtD
Acamprosate—Dermatitis—Memantine—Alzheimer's disease	5.99e-05	0.000511	CcSEcCtD
Acamprosate—Headache—Memantine—Alzheimer's disease	5.96e-05	0.000509	CcSEcCtD
Acamprosate—Vomiting—Rivastigmine—Alzheimer's disease	5.91e-05	0.000505	CcSEcCtD
Acamprosate—Rash—Rivastigmine—Alzheimer's disease	5.87e-05	0.000501	CcSEcCtD
Acamprosate—Dermatitis—Rivastigmine—Alzheimer's disease	5.86e-05	0.0005	CcSEcCtD
Acamprosate—Headache—Rivastigmine—Alzheimer's disease	5.83e-05	0.000498	CcSEcCtD
Acamprosate—Nausea—Memantine—Alzheimer's disease	5.65e-05	0.000482	CcSEcCtD
Acamprosate—Nausea—Rivastigmine—Alzheimer's disease	5.53e-05	0.000472	CcSEcCtD
Acamprosate—GRIN1—Developmental Biology—PRNP—Alzheimer's disease	2.71e-05	0.000309	CbGpPWpGaD
Acamprosate—GABRG2—Transmission across Chemical Synapses—DLG4—Alzheimer's disease	2.68e-05	0.000305	CbGpPWpGaD
Acamprosate—GRM5—GPCR ligand binding—CCL2—Alzheimer's disease	2.68e-05	0.000305	CbGpPWpGaD
Acamprosate—GABRB3—Neuronal System—CHRNB2—Alzheimer's disease	2.68e-05	0.000305	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—CREB1—Alzheimer's disease	2.67e-05	0.000304	CbGpPWpGaD
Acamprosate—GABRB3—Transmission across Chemical Synapses—GRIN2B—Alzheimer's disease	2.67e-05	0.000304	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—PTGS2—Alzheimer's disease	2.67e-05	0.000303	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—PRNP—Alzheimer's disease	2.65e-05	0.000301	CbGpPWpGaD
Acamprosate—GABRB3—Transmission across Chemical Synapses—PLCB1—Alzheimer's disease	2.64e-05	0.0003	CbGpPWpGaD
Acamprosate—GABRG2—Neuronal System—CHRNB2—Alzheimer's disease	2.63e-05	0.000299	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PSENEN—Alzheimer's disease	2.63e-05	0.000299	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—PSEN2—Alzheimer's disease	2.63e-05	0.000299	CbGpPWpGaD
Acamprosate—GABRG2—Transmission across Chemical Synapses—GRIN2B—Alzheimer's disease	2.62e-05	0.000298	CbGpPWpGaD
Acamprosate—GRIN2A—Neuronal System—PRKCG—Alzheimer's disease	2.6e-05	0.000296	CbGpPWpGaD
Acamprosate—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKCG—Alzheimer's disease	2.6e-05	0.000296	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—APH1A—Alzheimer's disease	2.59e-05	0.000295	CbGpPWpGaD
Acamprosate—GABRG2—Transmission across Chemical Synapses—PLCB1—Alzheimer's disease	2.59e-05	0.000295	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—MEF2C—Alzheimer's disease	2.59e-05	0.000295	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—PLCB1—Alzheimer's disease	2.56e-05	0.000292	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—PSEN2—Alzheimer's disease	2.56e-05	0.000292	CbGpPWpGaD
Acamprosate—GRIN1—Transmission across Chemical Synapses—CALM1—Alzheimer's disease	2.56e-05	0.000291	CbGpPWpGaD
Acamprosate—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKCG—Alzheimer's disease	2.55e-05	0.00029	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—NCSTN—Alzheimer's disease	2.52e-05	0.000287	CbGpPWpGaD
Acamprosate—GRIN2C—Neuronal System—CREB1—Alzheimer's disease	2.52e-05	0.000287	CbGpPWpGaD
Acamprosate—GRIN1—EPH-Ephrin signaling—VEGFA—Alzheimer's disease	2.52e-05	0.000287	CbGpPWpGaD
Acamprosate—GRIN2A—Transmission across Chemical Synapses—CREB1—Alzheimer's disease	2.51e-05	0.000286	CbGpPWpGaD
Acamprosate—GRIN2A—Alzheimers Disease—TP53—Alzheimer's disease	2.51e-05	0.000285	CbGpPWpGaD
Acamprosate—GRIN2B—Transmission across Chemical Synapses—CALM1—Alzheimer's disease	2.49e-05	0.000284	CbGpPWpGaD
Acamprosate—GRIN1—Alzheimers Disease—TNF—Alzheimer's disease	2.48e-05	0.000282	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—IL1B—Alzheimer's disease	2.48e-05	0.000282	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—ADAM10—Alzheimer's disease	2.48e-05	0.000282	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—CASP3—Alzheimer's disease	2.47e-05	0.000282	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—NGF—Alzheimer's disease	2.47e-05	0.000281	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—LRP1—Alzheimer's disease	2.46e-05	0.00028	CbGpPWpGaD
Acamprosate—GABRB3—Neuronal System—ACHE—Alzheimer's disease	2.46e-05	0.00028	CbGpPWpGaD
Acamprosate—GRIN2B—EPH-Ephrin signaling—VEGFA—Alzheimer's disease	2.45e-05	0.000279	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—SLC30A6—Alzheimer's disease	2.44e-05	0.000278	CbGpPWpGaD
Acamprosate—SLC36A1—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	2.44e-05	0.000278	CbGpPWpGaD
Acamprosate—GABRB3—Neuronal System—CHRNA4—Alzheimer's disease	2.43e-05	0.000277	CbGpPWpGaD
Acamprosate—GABRA1—Neuronal System—GRIA1—Alzheimer's disease	2.43e-05	0.000276	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—APOD—Alzheimer's disease	2.42e-05	0.000276	CbGpPWpGaD
Acamprosate—GRIN2B—Alzheimers Disease—TNF—Alzheimer's disease	2.42e-05	0.000275	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—ADAM10—Alzheimer's disease	2.42e-05	0.000275	CbGpPWpGaD
Acamprosate—GABRG2—Neuronal System—ACHE—Alzheimer's disease	2.42e-05	0.000275	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—GFAP—Alzheimer's disease	2.4e-05	0.000274	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—GAL—Alzheimer's disease	2.4e-05	0.000274	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—IAPP—Alzheimer's disease	2.4e-05	0.000274	CbGpPWpGaD
Acamprosate—GABRA1—Transmission across Chemical Synapses—BCHE—Alzheimer's disease	2.4e-05	0.000273	CbGpPWpGaD
Acamprosate—GABRG2—Neuronal System—CHRNA4—Alzheimer's disease	2.39e-05	0.000272	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—APOD—Alzheimer's disease	2.38e-05	0.000271	CbGpPWpGaD
Acamprosate—GRIN2D—Neuronal System—CREB1—Alzheimer's disease	2.34e-05	0.000267	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—IAPP—Alzheimer's disease	2.34e-05	0.000267	CbGpPWpGaD
Acamprosate—GABRA1—Transmission across Chemical Synapses—DLG4—Alzheimer's disease	2.34e-05	0.000267	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—PPARGC1A—Alzheimer's disease	2.31e-05	0.000263	CbGpPWpGaD
Acamprosate—GABRA1—Neuronal System—CHRNB2—Alzheimer's disease	2.3e-05	0.000262	CbGpPWpGaD
Acamprosate—GABRA1—Transmission across Chemical Synapses—GRIN2B—Alzheimer's disease	2.29e-05	0.000261	CbGpPWpGaD
Acamprosate—GRIN1—Neuronal System—PRKCG—Alzheimer's disease	2.27e-05	0.000258	CbGpPWpGaD
Acamprosate—GABRA1—Transmission across Chemical Synapses—PLCB1—Alzheimer's disease	2.27e-05	0.000258	CbGpPWpGaD
Acamprosate—GRIN2A—Neuronal System—CALM1—Alzheimer's disease	2.25e-05	0.000256	CbGpPWpGaD
Acamprosate—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CALM1—Alzheimer's disease	2.25e-05	0.000256	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—BDNF—Alzheimer's disease	2.24e-05	0.000255	CbGpPWpGaD
Acamprosate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKCG—Alzheimer's disease	2.23e-05	0.000254	CbGpPWpGaD
Acamprosate—GRIN2B—Neuronal System—PRKCG—Alzheimer's disease	2.21e-05	0.000252	CbGpPWpGaD
Acamprosate—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CALM1—Alzheimer's disease	2.21e-05	0.000251	CbGpPWpGaD
Acamprosate—GRIN1—Transmission across Chemical Synapses—CREB1—Alzheimer's disease	2.19e-05	0.000249	CbGpPWpGaD
Acamprosate—GRIN1—Alzheimers Disease—TP53—Alzheimer's disease	2.19e-05	0.000249	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—IL1A—Alzheimer's disease	2.15e-05	0.000245	CbGpPWpGaD
Acamprosate—GABRB3—Neuronal System—BCHE—Alzheimer's disease	2.14e-05	0.000244	CbGpPWpGaD
Acamprosate—GRIN2B—Transmission across Chemical Synapses—CREB1—Alzheimer's disease	2.14e-05	0.000243	CbGpPWpGaD
Acamprosate—GRIN2B—Alzheimers Disease—TP53—Alzheimer's disease	2.13e-05	0.000243	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—A2M—Alzheimer's disease	2.12e-05	0.000241	CbGpPWpGaD
Acamprosate—GABRA1—Neuronal System—ACHE—Alzheimer's disease	2.11e-05	0.00024	CbGpPWpGaD
Acamprosate—GRIN1—BDNF signaling pathway—CASP3—Alzheimer's disease	2.11e-05	0.00024	CbGpPWpGaD
Acamprosate—GRM5—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Alzheimer's disease	2.11e-05	0.00024	CbGpPWpGaD
Acamprosate—GABRG2—Neuronal System—BCHE—Alzheimer's disease	2.1e-05	0.00024	CbGpPWpGaD
Acamprosate—GABRB3—Neuronal System—DLG4—Alzheimer's disease	2.09e-05	0.000238	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—PRKCG—Alzheimer's disease	2.09e-05	0.000238	CbGpPWpGaD
Acamprosate—GABRA1—Neuronal System—CHRNA4—Alzheimer's disease	2.09e-05	0.000238	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—MEF2C—Alzheimer's disease	2.08e-05	0.000237	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—APOD—Alzheimer's disease	2.08e-05	0.000237	CbGpPWpGaD
Acamprosate—GRIN2B—BDNF signaling pathway—CASP3—Alzheimer's disease	2.06e-05	0.000234	CbGpPWpGaD
Acamprosate—GABRG2—Neuronal System—DLG4—Alzheimer's disease	2.05e-05	0.000234	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PSEN2—Alzheimer's disease	2.05e-05	0.000234	CbGpPWpGaD
Acamprosate—GABRB3—Neuronal System—GRIN2B—Alzheimer's disease	2.04e-05	0.000233	CbGpPWpGaD
Acamprosate—GABRB3—Neuronal System—PLCB1—Alzheimer's disease	2.02e-05	0.00023	CbGpPWpGaD
Acamprosate—GABRG2—Neuronal System—GRIN2B—Alzheimer's disease	2.01e-05	0.000229	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—DLG4—Alzheimer's disease	2.01e-05	0.000229	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—NGF—Alzheimer's disease	1.99e-05	0.000227	CbGpPWpGaD
Acamprosate—GABRG2—Neuronal System—PLCB1—Alzheimer's disease	1.99e-05	0.000226	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—IL1B—Alzheimer's disease	1.98e-05	0.000226	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—CCR5—Alzheimer's disease	1.98e-05	0.000225	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—CASP3—Alzheimer's disease	1.98e-05	0.000225	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—GRIN2B—Alzheimer's disease	1.96e-05	0.000223	CbGpPWpGaD
Acamprosate—GRIN1—Neuronal System—CALM1—Alzheimer's disease	1.96e-05	0.000223	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—DLG4—Alzheimer's disease	1.96e-05	0.000223	CbGpPWpGaD
Acamprosate—GABRB3—Transmission across Chemical Synapses—PRKCG—Alzheimer's disease	1.95e-05	0.000222	CbGpPWpGaD
Acamprosate—GRIN1—BDNF signaling pathway—MAPK8—Alzheimer's disease	1.94e-05	0.000221	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—HTR2A—Alzheimer's disease	1.94e-05	0.000221	CbGpPWpGaD
Acamprosate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CALM1—Alzheimer's disease	1.93e-05	0.000219	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—TGFB1—Alzheimer's disease	1.93e-05	0.000219	CbGpPWpGaD
Acamprosate—GRIN2A—Neuronal System—CREB1—Alzheimer's disease	1.92e-05	0.000219	CbGpPWpGaD
Acamprosate—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CREB1—Alzheimer's disease	1.92e-05	0.000219	CbGpPWpGaD
Acamprosate—GABRG2—Transmission across Chemical Synapses—PRKCG—Alzheimer's disease	1.92e-05	0.000218	CbGpPWpGaD
Acamprosate—GRIN2B—Neuronal System—CALM1—Alzheimer's disease	1.91e-05	0.000218	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—PRKCG—Alzheimer's disease	1.9e-05	0.000216	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—GSK3B—Alzheimer's disease	1.9e-05	0.000216	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—HTR2A—Alzheimer's disease	1.89e-05	0.000216	CbGpPWpGaD
Acamprosate—GRIN2B—BDNF signaling pathway—MAPK8—Alzheimer's disease	1.89e-05	0.000215	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—NPY—Alzheimer's disease	1.89e-05	0.000215	CbGpPWpGaD
Acamprosate—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CREB1—Alzheimer's disease	1.89e-05	0.000215	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—CREB1—Alzheimer's disease	1.88e-05	0.000214	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—IAPP—Alzheimer's disease	1.88e-05	0.000214	CbGpPWpGaD
Acamprosate—GABRA1—Neuronal System—BCHE—Alzheimer's disease	1.84e-05	0.000209	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CRH—Alzheimer's disease	1.82e-05	0.000207	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—TNF—Alzheimer's disease	1.8e-05	0.000205	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—CCR5—Alzheimer's disease	1.8e-05	0.000205	CbGpPWpGaD
Acamprosate—GABRA1—Neuronal System—DLG4—Alzheimer's disease	1.8e-05	0.000204	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—ADAM10—Alzheimer's disease	1.77e-05	0.000201	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—HTR2A—Alzheimer's disease	1.76e-05	0.0002	CbGpPWpGaD
Acamprosate—GABRA1—Neuronal System—GRIN2B—Alzheimer's disease	1.75e-05	0.0002	CbGpPWpGaD
Acamprosate—GABRA1—Neuronal System—PLCB1—Alzheimer's disease	1.74e-05	0.000198	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—NPS—Alzheimer's disease	1.73e-05	0.000197	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—ADAM10—Alzheimer's disease	1.72e-05	0.000196	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PPP3CA—Alzheimer's disease	1.72e-05	0.000196	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—F2—Alzheimer's disease	1.7e-05	0.000193	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PTK2B—Alzheimer's disease	1.69e-05	0.000193	CbGpPWpGaD
Acamprosate—GABRB3—Transmission across Chemical Synapses—CALM1—Alzheimer's disease	1.69e-05	0.000192	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—VEGFA—Alzheimer's disease	1.68e-05	0.000191	CbGpPWpGaD
Acamprosate—GRIN1—Neuronal System—CREB1—Alzheimer's disease	1.68e-05	0.000191	CbGpPWpGaD
Acamprosate—GABRA1—Transmission across Chemical Synapses—PRKCG—Alzheimer's disease	1.68e-05	0.000191	CbGpPWpGaD
Acamprosate—GABRG2—Transmission across Chemical Synapses—CALM1—Alzheimer's disease	1.66e-05	0.000189	CbGpPWpGaD
Acamprosate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CREB1—Alzheimer's disease	1.65e-05	0.000188	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—GAB2—Alzheimer's disease	1.65e-05	0.000188	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—NTRK2—Alzheimer's disease	1.65e-05	0.000188	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—SST—Alzheimer's disease	1.65e-05	0.000188	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—CALM1—Alzheimer's disease	1.64e-05	0.000187	CbGpPWpGaD
Acamprosate—GRIN2B—Neuronal System—CREB1—Alzheimer's disease	1.64e-05	0.000186	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—GSK3A—Alzheimer's disease	1.63e-05	0.000186	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—PPARGC1A—Alzheimer's disease	1.62e-05	0.000185	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—APP—Alzheimer's disease	1.61e-05	0.000183	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—TP53—Alzheimer's disease	1.59e-05	0.000181	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—PPARGC1A—Alzheimer's disease	1.58e-05	0.00018	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—F2—Alzheimer's disease	1.54e-05	0.000176	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—CP—Alzheimer's disease	1.52e-05	0.000173	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PLCB1—Alzheimer's disease	1.52e-05	0.000172	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—CREB1—Alzheimer's disease	1.51e-05	0.000172	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—GSK3B—Alzheimer's disease	1.5e-05	0.000171	CbGpPWpGaD
Acamprosate—GABRB3—Neuronal System—PRKCG—Alzheimer's disease	1.5e-05	0.00017	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—CP—Alzheimer's disease	1.49e-05	0.00017	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—CREB1—Alzheimer's disease	1.49e-05	0.00017	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—LPL—Alzheimer's disease	1.48e-05	0.000168	CbGpPWpGaD
Acamprosate—GABRG2—Neuronal System—PRKCG—Alzheimer's disease	1.47e-05	0.000167	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—GSK3B—Alzheimer's disease	1.46e-05	0.000167	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—MEF2C—Alzheimer's disease	1.46e-05	0.000167	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—IL6—Alzheimer's disease	1.45e-05	0.000165	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—CREB1—Alzheimer's disease	1.45e-05	0.000165	CbGpPWpGaD
Acamprosate—GABRA1—Transmission across Chemical Synapses—CALM1—Alzheimer's disease	1.45e-05	0.000165	CbGpPWpGaD
Acamprosate—GABRB3—Transmission across Chemical Synapses—CREB1—Alzheimer's disease	1.45e-05	0.000165	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—TNF—Alzheimer's disease	1.44e-05	0.000164	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—LPL—Alzheimer's disease	1.44e-05	0.000164	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—MEF2C—Alzheimer's disease	1.43e-05	0.000162	CbGpPWpGaD
Acamprosate—GABRG2—Transmission across Chemical Synapses—CREB1—Alzheimer's disease	1.42e-05	0.000162	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—NGFR—Alzheimer's disease	1.41e-05	0.000161	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—CREB1—Alzheimer's disease	1.4e-05	0.00016	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—CASP3—Alzheimer's disease	1.39e-05	0.000158	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—ADAM10—Alzheimer's disease	1.38e-05	0.000157	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—CCL2—Alzheimer's disease	1.37e-05	0.000156	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—S100B—Alzheimer's disease	1.31e-05	0.000149	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—CP—Alzheimer's disease	1.3e-05	0.000149	CbGpPWpGaD
Acamprosate—GABRB3—Neuronal System—CALM1—Alzheimer's disease	1.29e-05	0.000147	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—TF—Alzheimer's disease	1.29e-05	0.000147	CbGpPWpGaD
Acamprosate—GABRA1—Neuronal System—PRKCG—Alzheimer's disease	1.28e-05	0.000146	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—MAPK8—Alzheimer's disease	1.28e-05	0.000146	CbGpPWpGaD
Acamprosate—GABRG2—Neuronal System—CALM1—Alzheimer's disease	1.27e-05	0.000145	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—TF—Alzheimer's disease	1.27e-05	0.000145	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—IGF2—Alzheimer's disease	1.24e-05	0.000142	CbGpPWpGaD
Acamprosate—GABRA1—Transmission across Chemical Synapses—CREB1—Alzheimer's disease	1.24e-05	0.000141	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—LEP—Alzheimer's disease	1.24e-05	0.000141	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—LEP—Alzheimer's disease	1.21e-05	0.000137	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—IGF1R—Alzheimer's disease	1.2e-05	0.000137	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—IL6—Alzheimer's disease	1.16e-05	0.000132	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—LPL—Alzheimer's disease	1.15e-05	0.000131	CbGpPWpGaD
Acamprosate—GRIN1—BDNF signaling pathway—AKT1—Alzheimer's disease	1.14e-05	0.00013	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—MEF2C—Alzheimer's disease	1.14e-05	0.00013	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—NOTCH1—Alzheimer's disease	1.14e-05	0.00013	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—IL1B—Alzheimer's disease	1.12e-05	0.000128	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—CASP3—Alzheimer's disease	1.12e-05	0.000128	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PRKCG—Alzheimer's disease	1.12e-05	0.000128	CbGpPWpGaD
Acamprosate—GRIN2B—BDNF signaling pathway—AKT1—Alzheimer's disease	1.11e-05	0.000127	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—NOTCH1—Alzheimer's disease	1.11e-05	0.000127	CbGpPWpGaD
Acamprosate—GABRA1—Neuronal System—CALM1—Alzheimer's disease	1.11e-05	0.000126	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—TF—Alzheimer's disease	1.11e-05	0.000126	CbGpPWpGaD
Acamprosate—GABRB3—Neuronal System—CREB1—Alzheimer's disease	1.11e-05	0.000126	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—NGF—Alzheimer's disease	1.09e-05	0.000124	CbGpPWpGaD
Acamprosate—GABRG2—Neuronal System—CREB1—Alzheimer's disease	1.09e-05	0.000124	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—PPARG—Alzheimer's disease	1.08e-05	0.000123	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—GSK3B—Alzheimer's disease	1.07e-05	0.000122	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—CREB1—Alzheimer's disease	1.06e-05	0.000121	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CCR5—Alzheimer's disease	1.06e-05	0.000121	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—INS—Alzheimer's disease	1.06e-05	0.00012	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—PPARG—Alzheimer's disease	1.05e-05	0.00012	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—GSK3B—Alzheimer's disease	1.04e-05	0.000119	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—HTR2A—Alzheimer's disease	1.04e-05	0.000118	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—CREB1—Alzheimer's disease	1.04e-05	0.000118	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—INS—Alzheimer's disease	1.03e-05	0.000117	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CALM1—Alzheimer's disease	9.69e-06	0.00011	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—LEP—Alzheimer's disease	9.66e-06	0.00011	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—APOE—Alzheimer's disease	9.66e-06	0.00011	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CAV1—Alzheimer's disease	9.57e-06	0.000109	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—VEGFA—Alzheimer's disease	9.51e-06	0.000108	CbGpPWpGaD
Acamprosate—GABRA1—Neuronal System—CREB1—Alzheimer's disease	9.51e-06	0.000108	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—VEGFA—Alzheimer's disease	9.36e-06	0.000107	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—ESR1—Alzheimer's disease	9.22e-06	0.000105	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—VEGFA—Alzheimer's disease	9.12e-06	0.000104	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—F2—Alzheimer's disease	9.11e-06	0.000104	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	9.04e-06	0.000103	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—NOTCH1—Alzheimer's disease	8.91e-06	0.000101	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	8.88e-06	0.000101	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—GSK3B—Alzheimer's disease	8.37e-06	9.52e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CREB1—Alzheimer's disease	8.3e-06	9.45e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—INS—Alzheimer's disease	8.25e-06	9.39e-05	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—TNF—Alzheimer's disease	8.15e-06	9.28e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CCL2—Alzheimer's disease	8.12e-06	9.24e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—IGF1—Alzheimer's disease	7.98e-06	9.09e-05	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	7.76e-06	8.83e-05	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—AKT1—Alzheimer's disease	7.54e-06	8.58e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—NOS3—Alzheimer's disease	7.24e-06	8.24e-05	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—VEGFA—Alzheimer's disease	6.68e-06	7.6e-05	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—IL6—Alzheimer's disease	6.58e-06	7.49e-05	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—VEGFA—Alzheimer's disease	6.51e-06	7.41e-05	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—IL6—Alzheimer's disease	6.47e-06	7.37e-05	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—IL6—Alzheimer's disease	6.31e-06	7.18e-05	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—AKT1—Alzheimer's disease	6.2e-06	7.06e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CASP3—Alzheimer's disease	6.14e-06	6.99e-05	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—TGFB1—Alzheimer's disease	6.13e-06	6.98e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—IL6—Alzheimer's disease	6.1e-06	6.95e-05	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—TGFB1—Alzheimer's disease	5.97e-06	6.8e-05	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—TNF—Alzheimer's disease	5.72e-06	6.52e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—MAPK8—Alzheimer's disease	5.65e-06	6.43e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—AKT1—Alzheimer's disease	5.63e-06	6.41e-05	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—TNF—Alzheimer's disease	5.58e-06	6.35e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—VEGFA—Alzheimer's disease	5.21e-06	5.94e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—TGFB1—Alzheimer's disease	4.79e-06	5.45e-05	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—IL6—Alzheimer's disease	4.62e-06	5.26e-05	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—IL6—Alzheimer's disease	4.5e-06	5.13e-05	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—AKT1—Alzheimer's disease	4.26e-06	4.85e-05	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—AKT1—Alzheimer's disease	4.15e-06	4.73e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—TP53—Alzheimer's disease	3.94e-06	4.48e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—IL6—Alzheimer's disease	3.61e-06	4.1e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—AKT1—Alzheimer's disease	3.33e-06	3.79e-05	CbGpPWpGaD
